Literature DB >> 18018814

Abuse of buprenorphine in the United States: 2003-2005.

Meredith Y Smith1, J Elise Bailey, George E Woody, Herbert D Kleber.   

Abstract

This study examines trends in the reported abuse of two sublingual buprenorphine products, Subutex and Suboxone, in the United States. Quarterly counts of abuse cases were obtained from 18 regional poison control centers (PCCS) for 2003-2005. Seventy-seven abuse cases were reported, of which 7.8 percent involved Subutex and 92.2 percent involved Suboxone. The average quarterly ratio of abuse cases per 1,000 prescriptions dispensed was 0.08 (SD +/- 0.09) for Subutex, and 0.16 (SD +/- 0.08) for Suboxone. Findings suggest that these sublingual buprenorphine formulations have a low rate of abuse based on toxico-surveillance data.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18018814     DOI: 10.1300/J069v26n03_12

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  13 in total

1.  Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy.

Authors:  Heather Hamza; Ethan O Bryson
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

2.  Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland.

Authors:  Becky L Genberg; Mirinda Gillespie; Charles R Schuster; Chris-Ellyn Johanson; Jacquie Astemborski; Gregory D Kirk; David Vlahov; Shruti H Mehta
Journal:  Addict Behav       Date:  2013-08-17       Impact factor: 3.913

Review 3.  Strategies to prevent opioid misuse, abuse, and diversion that may also reduce the associated costs.

Authors:  Kathryn L Hahn
Journal:  Am Health Drug Benefits       Date:  2011-03

4.  Determinants of fentanyl and other potent µ opioid agonist misuse in opioid-dependent individuals.

Authors:  Theodore J Cicero; Matthew S Ellis; Alethea Paradis; Zachary Ortbal
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-10       Impact factor: 2.890

5.  Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids.

Authors:  Raminta Daniulaityte; Russel Falck; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2011-10-28       Impact factor: 4.492

Review 6.  Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

Authors:  Michael A Yokell; Nickolas D Zaller; Traci C Green; Josiah D Rich
Journal:  Curr Drug Abuse Rev       Date:  2011-03

7.  Consumer attitudes about opioid addiction treatment: a focus group study in New York City.

Authors:  Nancy L Sohler; Linda Weiss; James E Egan; Carolina M López; Jamie Favaro; Robert Cordero; Chinazo O Cunningham
Journal:  J Opioid Manag       Date:  2013 Mar-Apr

8.  Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.

Authors:  Shannon Gwin Mitchell; Sharon M Kelly; Barry S Brown; Heather Schacht Reisinger; James A Peterson; Adrienne Ruhf; Michael H Agar; Kevin E O'Grady; Robert P Schwartz
Journal:  Am J Addict       Date:  2009 Sep-Oct

9.  Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.

Authors:  Stephen Magura; Joshua D Lee; Jason Hershberger; Herman Joseph; Lisa Marsch; Carol Shropshire; Andrew Rosenblum
Journal:  Drug Alcohol Depend       Date:  2008-10-18       Impact factor: 4.492

Review 10.  Opioids and the treatment of chronic pain: controversies, current status, and future directions.

Authors:  Andrew Rosenblum; Lisa A Marsch; Herman Joseph; Russell K Portenoy
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.